Share Source: TechCrunch
OpenAI founder and ChatGPT creator Sam Altman shared with reporters that he is actively developing his new project, called Merge Labs. This startup has a very specific goal – to create a non-invasive brain-computer interface.
Main theses:
- Merge Labs promises to revolutionize the way humans interact with artificial intelligence.
- This neurointerface is known for its unique ability to interact with neurons at the molecular level using ultrasound.
Merge Labs' neural interface is already in the process of being created
Altman's new project has every chance of becoming a serious competitor to Neuralink from American billionaire Elon Musk.
Its main advantage is that this interface will be able to work without being implanted into brain tissue.
According to the developers, the chip will connect to neurons at the molecular level and transmit information via ultrasound.
The largest investor was OpenAI, which paid Merge Labs $250 million at a valuation of $850 million. Investors include Bain Capital and Valve CEO Gabe Newell. According to the developers, such interfaces will become the basis for a new interaction between humans and AI.
Share
Sam Altman and his team realize that it may take not just years, but decades to realize their plan.
However, even this does not stop the developers, who have already received considerable funding.
Merge Labs plans to engage in important research in the near future.
Moreover, it is known that trials have begun on patients with traumatic brain injuries.